{"id":5451,"date":"2014-02-27T16:31:29","date_gmt":"2014-02-27T15:31:29","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=5451"},"modified":"2014-02-27T16:31:29","modified_gmt":"2014-02-27T15:31:29","slug":"linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/","title":{"rendered":"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria"},"content":{"rendered":"<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/02\/cofb.140213-32.jpg\"><img decoding=\"async\" class=\"alignleft  wp-image-5453\" alt=\"cofb.140213-32\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/02\/cofb.140213-32.jpg\" width=\"269\" height=\"179\" \/><\/a>El Pla de Salut 2011-2015 \u00e9s un document estrat\u00e8gic que articula la reforma del sistema sanitari i comporta la implicaci\u00f3 del farmac\u00e8utic en part de les seves l\u00ednies estrat\u00e8giques, alhora que marca la necessitat d\u2019afrontar el repte estructural\u00a0 de la cronicitat, amb una estrat\u00e8gia de canvi integral en el model assistencial. D\u2019aquestes premisses parteix el curs que acull el Col\u00b7legi anomenat \u201cLes l\u00ednies estrat\u00e8giques del Pla de Salut: implicacions per a la farm\u00e0cia comunit\u00e0ria\u201d. Coordinat per Merc\u00e8 Barau, vocal de la Junta de Govern del COFB, <strong>les sessions persegueixen l\u2019objectiu de revisar els principals grups estrat\u00e8gics per formar els farmac\u00e8utics en les funcions assistencials que poden fer des de l\u2019oficina de farm\u00e0cia.<\/strong><\/p>\n<p><span style=\"color: #808080;\" data-mce-mark=\"1\"><b>El document es fonamenta en tres eixos: donar resposta a les noves necessitats socials, establir els objectius de salut a assolir i concretar les accions priorit\u00e0ries a dur a terme per afrontar les necessitats detectades, com ara els h\u00e0bits de vida poc saludables que comporten l\u2019aparici\u00f3 de malalties com la diabetis, el c\u00e0ncer, l&#8217;MPOC i la insufici\u00e8ncia card\u00edaca i respirat\u00f2ria. <\/b><\/span><\/p>\n<p>Cada tema s\u2019imparteix en dues sessions (una te\u00f2rica i l\u2019altra de taller), excepte l\u2019\u00faltima que \u00e9s una sessi\u00f3 \u00fanica. El tema escollit per la primera classe, que va tenir lloc el 13 de febrer, va ser el tractament\u00a0 de la malaltia pulmonar obstructiva cr\u00f2nica (MPOC) i el proper 13 de mar\u00e7 els alumnes assistiran a un taller de maneig d\u2019inhaladors. Els altres temes que s\u2019abordaran seran la diabetis (8 de maig), un taller d\u2019insulinitzaci\u00f3 (12 de juny), la insufici\u00e8ncia card\u00edaca a l\u2019atenci\u00f3 prim\u00e0ria (19 de juny), taller d\u2019AMPA\/MAPA (3 de juliol) i una sessi\u00f3 final sobre cronicitat a Catalunya (18 de setembre).<\/p>\n<p>El curs, patrocinat per <span style=\"text-decoration: underline;\">Esteve<\/span>, <strong>est\u00e0 adre\u00e7at a farmac\u00e8utics d\u2019oficina de farm\u00e0cia familiaritzats amb els conceptes d\u2019atenci\u00f3 farmac\u00e8utica o b\u00e9 que formen part d\u2019algun programa d\u2019atenci\u00f3 farmac\u00e8utica<\/strong>, com ara el FarmaEPOC o el test r\u00e0pid de detecci\u00f3 de VIH.<\/p>\n<p>El professorat que participa en aquestes sessions \u00e9s el seg\u00fcent:<\/p>\n<ul>\n<li>Mariano De la Figuera, grup de treball d\u2019hipertensi\u00f3 arterial de la CAMFiC<\/li>\n<li>\u00a0Xavier Flor, grup de treball de malalties respirat\u00f2ries de la CAMFiC<\/li>\n<li>S\u00f2nia Fuentes, grup de treball de malalties del cor de la CAMFiC<\/li>\n<li>Manel Mata, grup de treball de GEDAPS (Grup d\u2019Estudi sobre Diabetis a l\u2019APS)<\/li>\n<li>Sonia P\u00e9rez, metge de la Direcci\u00f3 d&#8217;Atenci\u00f3 Prim\u00e0ria del CIS, Cotxeres<\/li>\n<\/ul>\n<h6 style=\"text-align: right;\"><span style=\"color: #808080;\"><strong>Amb el patrocini de:<\/strong><\/span><\/h6>\n<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/02\/esteve.jpg\"><img decoding=\"async\" class=\" wp-image-5489 alignright\" alt=\"esteve\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/02\/esteve.jpg\" width=\"137\" height=\"53\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Pla de Salut 2011-2015 \u00e9s un document estrat\u00e8gic que articula la reforma del sistema sanitari i comporta la implicaci\u00f3 del farmac\u00e8utic en part de les seves l\u00ednies estrat\u00e8giques, alhora que marca la necessitat d\u2019afrontar el repte estructural\u00a0 de la cronicitat, amb una estrat\u00e8gia de canvi integral en el model [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5453,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[70,76],"class_list":["post-5451","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-formacio","tag-oficina-de-farmacia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El Pla de Salut 2011-2015 \u00e9s un document estrat\u00e8gic que articula la reforma del sistema sanitari i comporta la implicaci\u00f3 del farmac\u00e8utic en part de les seves l\u00ednies estrat\u00e8giques, alhora que marca la necessitat d\u2019afrontar el repte estructural\u00a0 de la cronicitat, amb una estrat\u00e8gia de canvi integral en el model [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-02-27T15:31:29+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria\",\"datePublished\":\"2014-02-27T15:31:29+00:00\",\"dateModified\":\"2014-02-27T15:31:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\"},\"wordCount\":453,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Formaci\u00f3\",\"Oficina de farm\u00e0cia\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\",\"name\":\"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2014-02-27T15:31:29+00:00\",\"dateModified\":\"2014-02-27T15:31:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/","og_locale":"ca_ES","og_type":"article","og_title":"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El Pla de Salut 2011-2015 \u00e9s un document estrat\u00e8gic que articula la reforma del sistema sanitari i comporta la implicaci\u00f3 del farmac\u00e8utic en part de les seves l\u00ednies estrat\u00e8giques, alhora que marca la necessitat d\u2019afrontar el repte estructural\u00a0 de la cronicitat, amb una estrat\u00e8gia de canvi integral en el model [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2014-02-27T15:31:29+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria","datePublished":"2014-02-27T15:31:29+00:00","dateModified":"2014-02-27T15:31:29+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/"},"wordCount":453,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage"},"thumbnailUrl":"","keywords":["Formaci\u00f3","Oficina de farm\u00e0cia"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/","url":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/","name":"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage"},"thumbnailUrl":"","datePublished":"2014-02-27T15:31:29+00:00","dateModified":"2014-02-27T15:31:29+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2014\/02\/27\/linies-estrategiques-del-pla-de-salut-implicacions-per-a-la-farmacia-comunitaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"L\u00ednies estrat\u00e8giques del Pla de salut: implicacions per a la farm\u00e0cia comunit\u00e0ria"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El Pla de Salut 2011-2015 \u00e9s un document estrat\u00e8gic que articula la reforma del sistema sanitari i comporta la implicaci\u00f3 del farmac\u00e8utic en part de les seves l\u00ednies estrat\u00e8giques, alhora que marca la necessitat d\u2019afrontar el repte estructural\u00a0 de la cronicitat, amb una estrat\u00e8gia de canvi integral en el model [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/5451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=5451"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/5451\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=5451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=5451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=5451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}